Process Development and Upstream Production
This 2,000 square foot cGMP BSL2 suite is subdivided to accommodate to multiplatform processes from bacteria (E. coli, etc.) to various mammalian cell (CHO, VERO, BHK, etc.) expression systems. Activities in this suite include upstream process development and manufacturing up to pre-clinical and Phase I scale. We have bioreactors from 1L to 100L working volumes, including single use, stainless steel, and wave-type systems that will also accommodate perfusion (see this lab’s equipment listed in the yellow side bar).